FDA approves GLP-1 weight loss pill Fondo from Eli Lilly

past

The Food and Drug Administration on Wednesday approved a new weight loss pill from drugmaker Eli Lilly. Subscribe to read this story without ads Get unlimited access to articles and exclusive content without ads. The daily pill, called Foundayo, is the second oral GLP-1 to hit the market in recent months, following the approval of … Read more

Eli Lilly and Ensilico Pharmaceuticals Sign AI-Driven R&D Agreement Worth $2.75 Billion

Eli Lilly and Ensilico Pharmaceuticals Sign AI-Driven R&D Agreement Worth $2.75 Billion

Eli Lilly is joining forces with artificial intelligence (AI)-powered biotech, Ensilico Medicines, in a $2.75 billion drug discovery and development deal. Through this collaboration, Lilly will use the Insilico Pharma.AI platform to support its novel therapeutic drug discovery and development efforts spanning multiple disease areas. Under the terms of the deal, Lilly will have exclusive … Read more